There are some really good looking oil stocks right now. Unfortunately, I have some kind of mental block with trading oil companies. It seems like every time I’ve tried to trade them some report comes out mid-day and stops me out. So I gave up trying to play them long ago.
Currently holding:
Long – CME, ZEUS, IIIN
Short – none
Looking for swing trade entries in:
Longs – AAPL, ABX, BTU, COGT, PLAY, SYNA
Shorts – CELG, FRX, PFE
Potential day trades:
(From Briefing.com)
Gapping Down
CGTK -41% (edifoligide failed to show a benefit; CSFB downgrade), MGPI -24% (lowers guidance), CC -7.5% (reports Q3 sales), PRCS -7.4% (expects Plenaxis sales to decline in Q4), SHOP -5.8% (started with a Sell at Deutsche; tgt $20), GORX -2.9% (announces lawsuit against the co relating to its announcement of Mucotrol’s FDA clearance), DISH -2.8%, TASR -2.4% (experts dispute data on stun guns — Miami Herald), NAV -1.6% (delays earnings report; guides), STLD -1.8% (UBS downgrade).
Gapping Up
IPXL +12.5% (gets final FDA approval and first-to-file status for generic Wellbutrin), SCMM +13% (to Supply cmputers With Smart Card readers for US Govt Programs), UNTD +9% (enters into credit deal with Deutsche), BIVN +10.3% (positive clinical data), MYGN +10% (Piper upgrade), PRVT +9.3% (positive Barron’s mention), VAST +8.4% (JMP upgrade), WHT +6.6% (to merge with GG — WSJ), NGEN +6.2% (awarded patent), ICOS +5.4% (UBS upgrade), TLCV +5%, ADSX +4.4%, CTIC +4% (clinical data), BMY +2.4% (launches first at-home test to measure blood sugar control), S +2.2% (Smith Barney says VNO may make bid), AAPL +1.8% (positive analyst comments)….. Under $3: GNTA +69% (announces positive clinical data for its anti-cancer drug), GEPT +64% (receives 60 plane order for its video systems), NERX +49% (provides updated STR trial data), CYTR +30% (positive clinical data), RITT +14.2%, WHRT +10%.
